Profile: Ipsen S.A. (IPN.PA)

IPN.PA on Paris Stock Exchange

39.73EUR
4:28am EST
Price Change (% chg)

€-0.22 (-0.55%)
Prev Close
€39.95
Open
€40.01
Day's High
€40.09
Day's Low
€39.73
Volume
39,218
Avg. Vol
82,392
52-wk High
€39.99
52-wk Low
€24.10

view overview for:
Ipsen SA is a France-based pharmaceutical company that produces a range of over 20 types of drugs. Its portfolio includes pharmaceutical products that are marketed to specialists working in the three therapeutic areas that the Company has prioritized for drug development: oncology, endocrinology and neuromuscular disorders. The Company also produces primary care therapeutic products for use in the fields of gastroenterology, cardiovascular problems and cognitive disorders. Its products are marketed in over 100 countries in Europe, North America and Asia. Ipsen SA has subsidiaries located across Europe, Asia, and North and South America, all of which are operated via its wholly owned SCRAS subsidiary, which is based in France. Ipsen SA is a subsidiary of the Mayroy group.

Company Address

Ipsen S.A.

42, rue du Docteur Blanche
Paris     75016
P: +331.44304343
F: +331.44304321

view overview for: